Attention Deficit-hyperactivity Disorder Clinical Trial
Official title:
Development and Assesment of TDApp1 an eHelath Tool to Make Participatory, Patient-centred and Automated Therapeutic Recommendations for Patients With Attention Deficit Hyperactivity Disorder
This is a 3-week open label, one group study to determine the agreement between the pharmacological treatment recommended by TDApp1 and the interventions recommended by relevant clinical practice guidelines.
Clinical practice guidelines (CPGP) allow optimizing medical decisions and health care based on the best evidence available. Nevertheless, CPGs have several limitations. First, many GPC are outdated shortly after their publication. Second, CPG recommendations are often not applicable to many patients treated in clinical practice. Most CPGs do not make recommendations for patients with a mild disorder or for complex patients with comorbiditie. Another limitation is that patients involvement in CPGs development is still poor. We aim to develop and assess TDApp1: an eHealth tool to formulate participatory, individualized and automated therapeutic recommendations for patients with Attention Deficit Hyperactivity Disorder. A 3-week, one group, open label study will be conducted. Fifty-five patients aged 6-65 with ADHD will use TDApp1. The therapeutic recommendations made by the TDApp1 and by relevant CPG will be compared. Concordance in the recommendations will be studied. Effectiveness, safety, changes in physical activity and satisfaction will be investigated. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04152629 -
Real World Evidence of the Efficacy and Safety of FOQUEST
|
Phase 4 | |
Completed |
NCT03003286 -
Community Based Intervention for Children With ADHD and ASD
|
N/A | |
Recruiting |
NCT04038073 -
TLR Polymorphism, ASO and Beta-hemolytic Group A Streptococcus Infections in ADHD: an Observational Study
|
||
Completed |
NCT01831622 -
Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder
|
Phase 4 | |
Completed |
NCT03847402 -
The Early Integrated Intervention for Child Brain-developmental Disorders in China
|
N/A | |
Withdrawn |
NCT01769300 -
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT03440346 -
Biomarker Research in ADHD: the Impact of Nutrition
|
N/A | |
Completed |
NCT04689282 -
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders
|
Phase 1/Phase 2 | |
Recruiting |
NCT02778360 -
Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder
|
Phase 1/Phase 2 |